Lingbin Shu
Impact in
- Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria
- Endocrinology top 1%
- Enterobacteriaceae and Cronobacter Research
- Vibrio bacteria research studies
Papers in
-
- Antibiotic Resistance in Bacteria 18
-
- Enterobacteriaceae and Cronobacter Research 7
- Escherichia coli research studies 2
- Co-authors
- Rong Zhang (18 shared papers)Sheng Chen (12 shared papers)Ning Dong (10 shared papers)Edward Wai‐Chi Chan (9 shared papers)Danxia Gu (4 shared papers)Zhiwei Zheng (3 shared papers)Lihua Wang (1 shared paper)Man Huang (1 shared paper)
- Journals
- Antimicrobial Agents and Chemotherapy (3 papers)Frontiers in Microbiology (2 papers)Journal of Clinical Microbiology (1 paper)Journal of Medical Microbiology (1 paper)The Lancet Infectious Diseases (1 paper)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Lingbin Shu
18 papers receiving 1.4k citations
Lingbin Shu's Hit Papers
Peers
Comparison fields: 5 of 50
- Molecular Medicine 1.2k
- Endocrinology 346
- Applied Microbiology and Biotechnology 72
- Clinical Biochemistry 165
- Pollution 196
Countries citing papers authored by Lingbin Shu
This map shows the geographic impact of Lingbin Shu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingbin Shu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingbin Shu more than expected).
Fields of papers citing papers by Lingbin Shu
This network shows the impact of papers produced by Lingbin Shu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingbin Shu. The network helps show where Lingbin Shu may publish in the future.
Co-authors
The 25 scholars most cited alongside Lingbin Shu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study Hit paper breakdown → | 2017 | 777 |
| 2 | 2021 | 77 | |
| 3 | 2018 | 70 | |
| 4 | 2018 | 68 | |
| 5 | 2020 | 63 | |
| 6 | 2018 | 63 | |
| 7 | 2020 | 50 | |
| 8 | 2021 | 37 | |
| 9 | 2018 | 33 | |
| 10 | 2019 | 28 | |
| 11 | 2019 | 26 | |
| 12 | 2020 | 21 | |
| 13 | 2023 | 21 | |
| 14 | 2019 | 20 | |
| 15 | 2019 | 12 | |
| 16 | 2023 | 11 | |
| 17 | 2018 | 8 | |
| 18 | 2019 | 6 |
About Lingbin Shu
Lingbin Shu is a scholar working on Molecular Medicine, Endocrinology, Molecular Biology, Pharmacology and Pollution, having authored 18 papers that have together received 1.4k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (18 papers), Enterobacteriaceae and Cronobacter Research (7 papers), Bacterial biofilms and quorum sensing (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Bacteriophages and microbial interactions (2 papers), Pharmaceutical and Antibiotic Environmental Impacts (2 papers), Escherichia coli research studies (2 papers) and Parasitic Infections and Diagnostics (1 paper). The work is most often cited by research in Molecular Medicine (1.2k citations), Endocrinology (346 citations), Applied Microbiology and Biotechnology (72 citations), Clinical Biochemistry (165 citations) and Pollution (196 citations). Lingbin Shu has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Rong Zhang, Sheng Chen, Ning Dong, Edward Wai‐Chi Chan, Danxia Gu, Zhiwei Zheng, Lihua Wang, Man Huang, Di Lin and Jiang Yu. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Frontiers in Microbiology, Journal of Clinical Microbiology, Journal of Medical Microbiology and The Lancet Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.